Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for Sleep and Depression in Parkinson's Disease
NCT03977441Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of agomelatine in sleep disorder, major depressive disorder (MDD), sponsored by The Second Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
agomelatine
03
Conditions
sleep disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03977441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977441.